Word

ONSURA

Status

Pending

Status Code

731

Status Date

Thursday, December 21, 2023

Serial Number

97336460

Mark Type

4000

Filing Date

Tuesday, March 29, 2022

Published for Opposition

Tuesday, November 1, 2022

Trademark Owner History

TEVA PHARMACEUTICALS USA, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the prevention and treatment of alzheimer's disease; pharmaceutical preparations for the prevention and treatment of depression; pharmaceutical preparations for the prevention and treatment of psychological disorders; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of osteoporosis; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of sexual dysfunction; pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; pharmaceutical preparations for the prevention and treatment of aids-related disorders; pharmaceutical preparations that support, encourage and promote bone strength; pharmaceutical preparations that support, encourage and promote bone health; pharmaceutical preparations used in the treatment of bone disorders and bone diseases; pharmaceutical preparations, namely, injectable contraceptives; pharmaceutical preparations, namely, contraceptive preparations; pharmaceutical preparations, namely, fertility enhancement preparations; pharmaceutical preparations, namely, hormone replacement therapy preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations, namely, pharmaceutical agents affecting the central nervous system; pharmaceutical preparations, namely, pharmaceutical agents affecting circulatory systems; pharmaceutical preparations, namely, pharmaceutical agents affecting sensory organs; pharmaceutical preparations, namely, pharmaceutical agents affecting urogenital organs; pharmaceutical preparations, namely, pharmaceutical agents affecting peripheral nervous system

Trademark Events

Dec 23, 2023

Notice Of Approval Of Extension Request E-Mailed

Dec 21, 2023

Sou Extension 2 Granted

Dec 21, 2023

Sou Extension 2 Filed

Dec 21, 2023

Sou Teas Extension Received

Aug 30, 2023

Notice Of Approval Of Extension Request E-Mailed

Aug 29, 2023

Sou Extension 1 Granted

Jun 27, 2023

Sou Extension 1 Filed

Aug 29, 2023

Case Assigned To Intent To Use Paralegal

Aug 2, 2023

Notice Of Revival - E-Mailed

Aug 1, 2023

Sou Extension Received With Teas Petition

Aug 1, 2023

Petition To Revive-Granted

Aug 1, 2023

Teas Petition To Revive Received

Jul 31, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

Jul 31, 2023

Abandonment - No Use Statement Filed

Dec 27, 2022

Noa E-Mailed - Sou Required From Applicant

Nov 1, 2022

Official Gazette Publication Confirmation E-Mailed

Nov 1, 2022

Published For Opposition

Oct 12, 2022

Notification Of Notice Of Publication E-Mailed

Sep 27, 2022

Approved For Pub - Principal Register

Sep 20, 2022

Assigned To Examiner

Apr 4, 2022

New Application Office Supplied Data Entered

Apr 1, 2022

New Application Entered